Position in MRK
as of Jun 30, 2026
· filed Jul 23, 2026
Position Value
$1,337,042
+$49,939 QoQ
Shares Held
10,405
-2.8% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.23%
of 13F equity value
Holder Rank
#1,880
of 3,769 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRK Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026AdvisorNet Financial, Inc holds $20,577,968 across 14 Drug Manufacturers - General names. MRK ranks #7 (6.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
15,169 | $3,852,470 | |
| 2 | GILD |
Gilead Sciences, Inc.
|
27,109 | $3,424,951 | |
| 3 | LLY |
ELI LILLY & Co
|
2,556 | $3,065,743 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
38,342 | $2,209,266 | |
| 5 | AZN |
Astrazeneca PLC
|
11,574 | $2,194,661 | |
| 6 | ABBV |
AbbVie Inc.
|
6,595 | $1,659,565 | |
| 7 | MRK |
Merck & Co., Inc.
This page
|
10,405 | $1,337,042 | |
| 8 | GSK |
GSK plc
|
17,988 | $942,930 |
All Filings in MRK
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,337,042 | 10,405 | Shares | Sole | 2026-07-23 | |
| 2026-03-31 | $1,287,103 | 10,700 | Shares | Sole | 2026-04-17 | |
| 2025-12-31 | $1,189,016 | 11,296 | Shares | Sole | 2026-01-20 | |
| 2025-09-30 | $1,002,292 | 11,942 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $1,108,714 | 14,006 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,429,068 | 15,921 | Shares | Sole | 2025-04-07 | |
| 2024-12-31 | $1,742,392 | 17,515 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $3,282,111 | 28,902 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $3,609,512 | 29,156 | Shares | Sole | 2024-07-16 | |
| 2024-03-31 | $3,885,267 | 29,445 | Shares | Sole | 2024-04-12 | |
| 2023-12-31 | $3,088,863 | 28,333 | Shares | Sole | 2024-01-19 | |
| 2023-09-30 | $2,967,739 | 28,827 | Shares | Sole | 2023-10-12 | |
| 2023-06-30 | $4,567,366 | 39,582 | Shares | Sole | 2023-07-14 | |
| 2023-03-31 | $4,319,965 | 40,605 | Shares | Sole | 2023-04-28 | |
| 2022-12-31 | $4,695,958 | 42,325 | Shares | Sole | 2023-01-13 | |
| 2022-09-30 | $3,672,415 | 42,643 | Shares | Sole | 2022-10-04 | |
| 2022-06-30 | $3,871,442 | 42,464 | Shares | Sole | 2022-07-07 | |
| 2022-03-31 | $3,491,965 | 42,559 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $2,386,109 | 31,134 | Shares | Sole | 2022-01-19 | |
| 2021-09-30 | $2,217,021 | 29,517 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $3,415,036 | 43,912 | Shares | Sole | 2021-07-06 | |
| 2021-03-31 | $3,336,457 | 43,280 | Shares | Sole | 2021-04-14 | |
| 2020-12-31 | $3,478,461 | 42,524 | Shares | Sole | 2021-02-04 | |
| 2020-09-30 | $3,711,184 | 44,740 | Shares | Sole | 2020-11-06 | |
| 2020-06-30 | $3,382,956 | 43,747 | Shares | Sole | 2020-08-26 | |
| 2020-03-31 | $3,270,641 | 42,509 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||